What is he best known for?
The fields of study he is best known for:
Lawrence A. Tabak focuses on Biochemistry, Polypeptide N-acetylgalactosaminyltransferase, Glycosylation, Threonine and Serine.
His study in Peptide sequence, Glycoprotein, Carbohydrate, Protein structure and Mucin is done as part of Biochemistry.
His Peptide sequence study combines topics from a wide range of disciplines, such as Structural motif and Transferase Gene.
He has included themes like Molecular biology, Northern blot and Gene isoform in his Polypeptide N-acetylgalactosaminyltransferase study.
His work investigates the relationship between Glycosylation and topics such as Glycan that intersect with problems in Gene family.
His Threonine research is multidisciplinary, relying on both Glycosyltransferase and Fucose.
His most cited work include:
- Policy: NIH plans to enhance reproducibility (834 citations)
- Control of mucin-type O-glycosylation: A classification of the polypeptide GalNAc-transferase gene family (460 citations)
- Role of salivary mucins in the protection of the oral cavity (435 citations)
What are the main themes of his work throughout his whole career to date?
Lawrence A. Tabak mainly investigates Biochemistry, Glycosylation, Molecular biology, Mucin and Saliva.
Peptide sequence, Peptide, Serine, Threonine and Gene isoform are subfields of Biochemistry in which his conducts study.
His Gene isoform study integrates concerns from other disciplines, such as Polypeptide N-acetylgalactosaminyltransferase and Glycoprotein.
His research investigates the connection between Glycosylation and topics such as Protein structure that intersect with issues in Active site.
Lawrence A. Tabak interconnects Submandibular gland, Chromatography, Carbohydrate and Fucose in the investigation of issues within Mucin.
His Saliva research incorporates themes from Endocrinology, Cysteine and Immunology.
He most often published in these fields:
- Biochemistry (46.58%)
- Glycosylation (21.92%)
- Molecular biology (19.86%)
What were the highlights of his more recent work (between 2011-2021)?
- Glycosylation (21.92%)
- Biochemistry (46.58%)
- Cell biology (8.90%)
In recent papers he was focusing on the following fields of study:
Lawrence A. Tabak mainly focuses on Glycosylation, Biochemistry, Cell biology, Transferase and Peptide.
His Glycosylation research integrates issues from Tropism, Serine, Gene, Mass spectrometry and Peptide bond.
His Biochemistry research focuses on Gene isoform, Isozyme, Mucin, Glycan and Gene family.
The concepts of his Gene isoform study are interwoven with issues in Peptide sequence, Subfamily and C-type lectin.
His Transferase research includes themes of Drosophila melanogaster, C-terminus and Binding domain.
His biological study spans a wide range of topics, including Lectin, Glycosyltransferase and Stereochemistry.
Between 2011 and 2021, his most popular works were:
- Policy: NIH plans to enhance reproducibility (834 citations)
- Control of mucin-type O-glycosylation: A classification of the polypeptide GalNAc-transferase gene family (460 citations)
- UDP-N-Acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferases: Completion of the Family Tree (55 citations)
In his most recent research, the most cited papers focused on:
His main research concerns Biochemistry, Glycosylation, Transferase, Peptide and Glycosyltransferase.
His work is connected to Mucin, Gene isoform, Glycan, O-linked glycosylation and Gene, as a part of Biochemistry.
Lawrence A. Tabak has researched Mucin in several fields, including Isozyme, Peptide sequence, Sequence alignment and Subfamily.
His Glycan research incorporates elements of Polypeptide N-acetylgalactosaminyltransferase, Serine and Gene family.
His Peptide study typically links adjacent topics like Lectin.
The Glycosyltransferase study combines topics in areas such as Uridine diphosphate, C-type lectin, Stereochemistry, Leaving group and Protein structure.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
